To facilitate the use of biological outcome modeling for treatment planning, an exponential function is introduced as a simpler equivalent to the Lyman formula for calculating normal tissue complication probability (NTCP). The single parameter of the exponential function is chosen to reproduce the Lyman calculation to within ∼0.3%, and thus enable easy conversion of data contained in empirical fits of Lyman parameters for organs at risk (OARs). 
Introduction
In three-dimensional conformal (3D) and particularly in intensity-modulated radiotherapy (IMRT) treatment planning, volumetric control of the dose distribution is determined through a multi-factorial, quantitative decision-making process. Dose distributions routinely involve partial irradiation of organs at risk (OARs), and OARs in the vicinity of a treatment target are often subjected to high-dose partial irradiation, with considerable potential for treatmentrelated complications. To avoid these risks, a planning decision might be made that results in an unnecessary reduction in dose to part of the target, possibly causing loss of effective palliation or probability of cure. Existing models for tumor control probability (TCP) might then be used to provide numerical estimates of those effects. In general, a planner chooses a balance between minimizing partial-volume irradiation of certain OARs to intermediate and high doses against partially irradiating other OARs, losing dose uniformity in target volumes or trimming geometric margins of the high-dose region around a defined target. To be objective in selecting a treatment plan, one would ideally engage a quantitative model to calculate complication probabilities for the various OARs. Such models exist, but are often not brought to bear in a planning process in part because parameters for particular organs are not considered well established or because models may be awkward to use. A tool to simplify calculating normal tissue complication probability (NTCP) can aid in the overall treatment planning process by facilitating estimates of the likelihood of adverse outcomes and together with tools for calculating TCP could promote an increase in both extent and sophistication of use of current treatment delivery capabilities.
Methods

Purpose of study, background and outline of method
The present work is aimed at facilitating the use of quantitative modeling of biological effects in treatment planning. This we attempt to do by constructing a new, simplified formula for one of the most widely employed phenomenological models for NTCP, then by deriving tissue parameters for the new equation. Our method is developed for the Lyman probit model (Lyman 1985) with the Kutcher-Burman (K-B) reduction algorithm Burman 1989, Kutcher et al 1991) for handling the general case of inhomogeneous organ irradiation, a model collectively known as the LKB model. The K-B reduction is a method for calculating the single effective fractional volume corresponding to irradiation to a particular reference dose, and thereby determining the NTCP from a formula of Lyman for NTCP from a partialvolume irradiation (Lyman 1985) .
We first provide a new derivation for the fact that in the LKB model, for a nonhomogeneously irradiated OAR, the uniform dose to the entire structure that would result in the same NTCP can be represented by the quantity referred to by Niemierko (1997 Niemierko ( , 1999 as the equivalent uniform dose (EUD). The same quantity had been introduced by Mohan et al (1992) as 'effective dose', and a method was described for deriving the above result, but the details of the derivation were omitted. The EUD as introduced by Niemierko (1997) was defined as the uniform dose that resulted in the survival of the same number of clonogens as the non-homogeneously irradiated tumor. The term was generalized by Niemierko (1999) to be associated with a concept of tolerance dose for non-homogeneously irradiated normal structures, and he proposed that the EUD for a general dose-volume histogram (dvh) be given by the generalized mean dose. The formula for the generalized mean dose is of the same form as the equation that appeared in Mohan et al (1992) .
We next observe that the Lyman formula for a uniformly irradiated OAR can be represented by an analytic approximation, specifically an exponential of a second-degree polynomial in dose. Using the new formalism we illustrate how model tissue parameters can readily be calculated for tissues previously fit to the LKB model. From the new formula and model tissue parameters, one can, by quite simple means, calculate the EUD for any pre-selected level of OAR complication probability. The method is used to generate a table of EUD across the complete range of NTCP, using the Lyman model parameters of Emami-Burman , as well as more recently fitted Lyman model parameters. A brief discussion and some speculation are offered regarding possible interpretation of the analytic formula.
Lyman model
In the Lyman model (Lyman 1985) , NTCP for uniform irradiation of an organ to dose D is given by
where
m is a dimensionless parameter and TD 50 is the whole organ dose for which NTCP is 50%. For the case of uniform irradiation of a fractional volume ν to dose D, Lyman (1985) gives the NTCP by the same formula with TD 50 replaced by a partial-volume-dependent parameter TD 50 (ν), given by
The exponent, with n > 0, is the parameter that determines volume dependence and (Kutcher and Burman 1989) . Then
In the LKB model, the total effective fractional volume irradiated to the dose d ref that would give the same NTCP as the inhomogeneously irradiated OAR is given as the sum of all the effective sub-volumes in the dvh:
Explicitly, the LKB model gives the NTCP by (1) with the variable u, given by
In K-B Burman 1989, Kutcher et al 1991) (3), (6) and (1). In the LKB model, NTCP is uniquely determined from the dvh. Consider now the case of a uniformly irradiated OAR. Since in this case, the Lyman model gives NTCP as a monotonically increasing function of dose, it follows that given an NTCP calculated by LKB, there is a unique uniform dose E that corresponds to this value of NTCP. In appendix A.2, we show that E is the quantity called the generalized EUD introduced by Niemierko (1999) .
Results
Relationship between the LKB variables and the EUD
It is shown in appendix A.2 that the EUD for an OAR calculated by the generalized Niemierko formula yields a dose which, if applied uniformly to the entire volume of the OAR, would result in the same NTCP as the effective volume Kutcher-Burman dvh reduction algorithm, calculated for any reference dose. Equation (A.8) of appendix A.2 is quoted here as (7):
This general property of the EUD suggests that a simplified formula for NTCP in terms of EUD dose E might prove useful as a mathematical tool for comparing treatment plans. The Lyman representation of NTCP in terms of the error function is not a simple formula inasmuch as it is expressed in the form of an integral, and is somewhat cumbersome to use. We shall see below that there is a simpler formula whose dose dependence is a very close approximation to that of the Lyman model.
An approximation for the Lyman formula
The most generally accepted feature of the phenomenological Lyman NTCP formula is that its shape is sigmoidal as a function of dose. Another property is that it is symmetric about the dose value for 50% complications, a feature that has not been tested directly, but that is in no apparent contradiction to clinical experience. The sigmoidal shape has provided a useful basis for fitting clinical data on treatment complications, and the fitted parameters m, n and TD 50 obtained from data from treatments performed using conventional fractionation of 1.8-2 Gy per fraction represent a distillation of considerable empirical clinical experience. Any alternative phenomenological formulation of the NTCP should preserve the sigmoidal dose-response model and, as a practical matter, should preserve in some form the data contained in the published fitting parameters. The formula to be introduced below will be seen to satisfy this criterion. Consider now the function ϕ(u) defined in (8) as a candidate to be used as an approximation for c(u) of (1) for u 0, (i.e. for dose D TD 50 ):
where u is defined in (2). The expression for ϕ(u) assumes the value 0.5 for u = 0, the same as c(u). As in LKB, for non-homogenous irradiation the quantity D of (2) would be replaced by E. For u > 0, i.e. (D > TD 50 ) we extend the definition of ϕ(u) by the equation 
0 : > u Figure 1 . The single-parameter quadratic exponential form of (8) and (9) This imposes the same symmetry about u = 0, i.e. D = TD 50 as in the Lyman model. In particular, the first and second derivatives are respectively symmetric and antisymmetric about u = 0, i.e. ϕ (u) = ϕ (−u) and ϕ (u) = −ϕ (−u), properties also of the Lyman function c(u). The form of (8) with its extension to u > 0 by (9) ensures continuity for the second derivative of ϕ(u) at u = 0, where ϕ (0) = 0. Higher even-order derivatives, however, are discontinuous at u = 0. The function ϕ(u) is plotted in figure 1 for several values for κ > 0. It can be seen that ϕ(u) displays sigmoidal behavior as a function of the variable u starting at 0 for u → −∞ increasing monotonically, reaching the value 0.5 as u passes through 0 and tending toward unity as u → ∞. Just as in the Lyman model, values of u < − 1 m correspond to negative values of dose D or E, and have no physical meaning.
Selecting the parameter κ for agreement with the Lyman equation.
To enable the new formula to be easily used with the modeling information established by previous fits of organ complication data to the parameters of the Lyman model, we select the parameter κ in (8) so that NTCP = ϕ(u) closely reproduces the values from the Lyman equation (1). For the sake of simplicity, we define κ by equating the NTCP of (8) to that of the Lyman model at a single point. For further simplicity, we choose the point u = −1. This value corresponds to a dose of NTCP of 15.9%, which is in a region of high clinical interest for the NTCP. From (B.3) of appendix B we obtain κ ≈ 0.8154, and as will be seen, turns out to offer a good fit.
The fit with this value is shown in figure 2. Deviations between the Lyman equation and the linear-quadratic exponential form are virtually indiscernible on the linear plot, although small deviations can be seen with a logarithmic presentation, as in the inset to figure 2. In this fit, the maximum difference between ϕ(u) and c(u) is 0.0033, i.e. 0.33%. 
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NTCP as a function of EUD.
For an OAR with Lyman parameters m and TD 50 , u and E are linearly related by (2), with E serving as the uniform dose D. Expression (8) for the NTCP ϕ(u) ≡ (E) can therefore be rewritten as a function of E as follows:
and
To summarize, (8) and (9) with parameter κ ≈ 0.8154 represent an approximation to the Lyman formula (1) for c(u) that is accurate to within 0.33% over the entire range −∞ < u < ∞.
Equations (10) and (11a)-(11c) represent the NTCP in terms of E and the Lyman parameters mand TD 50 . Since A, B and C are not all independent, C can be expressed in terms of A and B [equation (11c)]. Inverse formulae for mand TD 50 in terms of A and B are given in appendix C. For E > TD 50 , u > 0, and we use (9)
From (2) with E in place of D and from the last equality in (12), one can calculate A , B and C in terms of m and TD 50 or, equivalently, in terms of A and B. The calculations are given in appendix C.
Tissue parameters and EUD dose levels for complication rates
The formulae of (10) for E < TD 50 and (12) for E > TD 50 allow straightforward computation of E corresponding to pre-selected levels of complication. Thus for a selected value p = (E) < 0.5 of the NTCP, (10) applies, and taking the natural logarithm of both sides results in a quadratic equation for E with the solution
For NTCP ≡ p = (E) > 0.5, applying the same method to (12) results in
The conditions E < TD 50 and E > TD 50 for solutions of (10) and (12), respectively, restrict solutions for the two quadratic equations so that there is a unique solution for each.
EUDs for pre-determined complication rates using Emami parameters
The Lyman model tissue parameters were fitted by Burman et al (1991) to data on severe complications from treatment, such as pneumonitis for lungs, stricture or perforation for esophagus, liver failure for liver and necrosis, proctitis, stenosis or fistula for rectum. These data and the selection of endpoints were compiled from treatments at conventional fractionation of 1.8-2 Gy per fraction by Emami et al (1991) , and the fitted parameters are known as the Emami or Emami-Burman parameters. From these one can obtain the corresponding OAR quantities A, B, C and A , B , C , and in 
Application to organs at risk using modified Emami parameters
A number of reports have appeared which analyze treatment complication data for various organs in terms of the LKB model, for example, Seppenwoolde et al (2003) , Belderbos et al (2005) , Eisbruch et al (1999) , Rancati et al (2004) , Dawson et al (2002) , Chapet et al (2005) , Peeters et al (2006) , Cheung et al (2004) and Kwa et al (1998b) . These papers which appeared after the early report of Emami et al (1991) present analyses to determine new best-fit values for LKB model parameters. We have selected a sampling of several such recent LKB parameter fits from the literature for several organs, namely, esophagus (Belderbos et al 2005) , parotid (Eisbruch et al 1999) , lungs combined as a single organ (Seppenwoolde et al 2003) and rectum (Rancati et al 2004) , and we have included these in tables 1 and 2 for comparison. Each of the studies that were selected for inclusion in the tables was based on outcomes from more than 100 patients and found fitted LKB parameters that differed substantially from the Emami-Burman values.
Discussion
The phenomenological Lyman model gives the complication probability (NTCP) for an organ as a sigmoid-shaped function of the dose to which it is uniformly irradiated. We have seen Eisbruch et al (1999) . c Seppenwoolde et al (2003) . d Rancati et al (2004) .
that the LKB algorithm gives the same NTCP as uniform organ irradiation to dose E, where E is the equivalent uniform dose (EUD) of Niemierko (1999) . Expressing NTCP in terms of EUD represents a step toward simplifying the conceptual framework for modeling probability of expected complications using dvhs from a proposed treatment plan. A further step in the Table 2 . EUD (Gy) corresponding to indicated NTCP of OARs with Lyman parameters fitted by Burman et al (1991) for tissue complications from treatments with conventional fractionation. Last four rows: EUD for NTCP from parameters of more recent data as cited.
EUD ( Belderbos et al (2005) . b Eisbruch et al (1999) . c Seppenwoolde et al (2003) . d Rancati et al (2004) .
process of modeling NTCP in the LKB model has been found in a formula for NTCP as a second-degree polynomial exponential function of E that may be simpler to use than the Lyman equation. LKB model parameter fits for an organ have also been reported for restricted sets of patients, grouped according to different endpoints, or according to the presence or absence of previous treatment, such as whether prostate patients had previously undergone abdominal surgery (Peeters et al 2006) . Patients have been grouped by other medical factors, such as for example, whether a partial liver irradiation resulted from treatment of a primary or a metastatic liver tumor (Dawson et al 2002) . This approach suggests an area of application for the new formalism. Studies of different levels of complication or groupings of patients could expand the definition of what constitutes a population or type of treatment complication data that could be fitted directly to (10). From organ parameters fitted to the new formula, one could then obtain Lyman parameters if desired, by means of (C.1) and (C.2) of appendix C.
Summary
We have found a formula to represent NTCP as a function of EUD, and this formula may well be useful. The equation is an exponential of a second-degree polynomial of the EUD. In the general case of inhomogeneously irradiated OARs, normal tissue effects have been seen to be equally well represented by this new exponential formula as by the LKB model. Transformation formulae have been derived to connect organ parameters for the exponential with the Lyman parameters m and TD 50 . Tables of OAR parameters have been given, derived from published LKB model fits to the Emami OAR complication data and from LKB model fits to organ complication data from several recent studies. Simple equations have been given for the EUD that corresponds to any pre-selected level of NTCP. These equations have been applied to create a table of EUDs for different levels of complication probability for conventionally fractionated treatment of tissues for which LKB model parameters have been fitted.
Appendix A
A.1. NTCP in the LKB Model is independent of the choice of d ref
In the LKB calculation, for a given reference dose d ref , the effective volume is given by (4) and (5) from the text as 
This can be expanded as
From the LKB reduction, the NTCP for the choice of reference dose d ref is given by equations (1) to (3) of the text, with the variable u:
3) into (A.4b), the variable u may be written as
which is the form for u in the LKB reduction with the choice of reference dose d ref .
This proves the result that the NTCP in the LKB reduction is independent of the choice of reference dose.
A.2 In the LKB model, the NTCP of an inhomogeneously irradiated OAR is equal to NTCP for uniform irradiation of the OAR to a dose equal to the Niemierko EUD
The EUD is obtained by computing the dose contributions from N sub-volumes of equal fractional size 1/N unequally irradiated to dose d j (j = 1, 2, . . . , N) according to the generalized mean (Niemierko 1999, Abramowitz and Stegun 1964, p 10) , with the parameter a:
The sub-volumes may be considered voxels, and by summing over voxels irradiated to the same dose, the equation can be written for k unequal fractional sub-volumes (Mohan et al 1992 , Kwa et al 1998a , Niemierko 1999 :
Consider now the general case of an OAR with Lyman volume-dependence parameter n, and make the identification a = 1 n . Then, from (A.7) and abbreviating EUD by the symbol E
(A.8)
Now consider the Lyman model in which the entire volume is irradiated to the dose E, derived from the dvh using (A.8). Then the parameter u in equation (2) Now, (A.9) is identical to equation (6) in the text for the parameter u in the Kutcher-Burman reduction algorithm of the Lyman model. Therefore, for an inhomogeneously irradiated OAR, the equivalent uniform dose defined according to the generalized EUD formula (A.7) with the parameter a = 1 n gives the same NTCP as the LKB dvh reduction procedure. The NTCP is the same as when the OAR is subjected to uniform irradiation to dose E in the Lyman model. The result has been derived by Mohan et al (1992) , but to our knowledge the present derivation has not previously been published.
Appendix B
B.1. Calculation of parameter κ
As explained in the text, we have elected to approximately fit the function ϕ(u), defined in (8), to the Lyman NTCP function c(u), defined in (1), by selecting the parameter κ > 0 to force the value of ϕ(u) to be equal to that of c(u) at the point u = −1. Thus, 
